Catalytic asymmetric bromocyclizations of in situ generated carbamic acids from CO2 and allylamines were achieved via the use of a BINOL-derived chiral bifunctional selenide catalyst bearing a hydroxy group. Chiral 2-oxazolidinone products as important pharmaceutical building blocks were obtained with good enantioselectivities by the present catalytic asymmetric CO2 utilization reactions.